Development of a sublingual/oral formulation of ketamine for use in neuropathic pain: Preliminary findings from a three-way randomized, crossover study.

Source:http://linkedlifedata.com/resource/pubmed/id/19366273

Download in:

View as

General Info

PMID
19366273